chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Arm was sore where shot was given Saturday, 1:45PM March 6. Noticed slight muscle aches that afternoon. By 8PM those effects continued. I went to bed early and awoke in the night with extreme thirst and severe chills. I put on layers and heat was blasting near my head from below headboard.  I had a fever of 104 degrees which went down soon after I removed layers. I recall being very hard to get out of bed when the chills were at their worst so I was in a fetal position to try to stay warm. Sunday, thirst, chills and fever were gone, but I had an intermittent headache, sore arm where shot was given and my other arm!, also muscle aches and tiredness. By Monday, I had muscle aches,  tiredness and light-headedness; Tuesday I had slight nausea and headache a short while, but mainly tiredness. Wednesday, I still had soreness where shot was given, tiredness and light-headedness, but otherwise was feeling better.  I canceled plans Thursday involving heavy physical labor (native plant restoration)  just to rest a bit more. Basically, I had a bouquet of symptoms over several days - grateful not to have had all at once and can only imagine how bad coronavirus must be.
hives are mainly on her torso and thighs; This spontaneous case was reported by a pharmacist and describes the occurrence of URTICARIA in a 32-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Hives. Concomitant products included BENADRYL for an unknown indication.   On 02-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Apr-2021, the patient experienced URTICARIA. The patient was treated with Manual therapy (Oatmeal baths) for Urticaria. At the time of the report, URTICARIA outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported. Action taken with mRNA-1273 in response to events was not applicable.
Patient had a vaso vagal response to HPV #2. Patient responded well after nasal stimulant was introduced. Patient was made to lie die and take sips of room temperature water. Safely discharged home per provider.
Patient had a reaction with first vaccine. Opposite arm became tingly and rash developed in this arm. Was observed for 45 mins.    Took 50 mg Benadryl at home. Physician told her if it wasn't better in 3 hours to go to ER, Patient fell asleep and rash had faded when she woke up  At 2:40, ten minutes after this second dose, patient feels tingling in palm of left hand. 3:)) PM. No rash noted. Only tingling in palm of left hand.
On January 15, 2023 I experienced a EP-DVT had to have emergency surgery to suck Blood clots out of my lungs
Site soreness for 2 days, for the 2 mornings following felt mild flu like symptoms that were remedied by taking 1 tylenol
Patient had red rash around injection site that was warm to touch. Patient had headache. Rash appeared morning after injection. MD was notified and prescribed BENADRYL 50mg sig 1 now and then BID for 5 days and prednisone 10mg (60mg x2 days, 50mg x2 days, 40 x2 days, 30 x2 days, 20 x2 days, and 10 x2 days).
Patient was given a second Menactra injection. Had the first on one on 8-4-05 and another on 7-11-07.
Initial unsolicited report received from health care professional on 27-Sep-2017. This case involves a female patient (age and gender not reported) who was vaccinated with a dose of INFLUENZA VACCINE (Intradermal flu shot) (Batch number, expiration date, dose, route and site of administration was not reported) on an unknown date. The patient's medical history and concomitant medications were not reported. On an unspecified date, following the vaccination, the patient was diagnosed with cellulitis. Lab data was not reported. The patient received corrective treatment with prescribed antibiotics and hot compresses. The patient's event outcome was not reported. Upon internal review, the company decided to consider the event serious because of important medical event cellulitis. List of documents held by sender: none.; Sender's Comments: The patient experienced cellulitis post vaccination with INTRADERMAL FLU SHOT. Time to onset was not reported. No information regarding product brand name or lot number was reported. Patients medical history and condition at the time of vaccination was also missing. Cellulitis could have an infectious etiology totally unrelated to vaccination. Alternative etiologies should be investigated and ruled out before assessing the case. Additional information regarding patients medical history and product information should be requested. Based upon reported information the role of the vaccine can not be assessed.
Rash started 3-4 days after Bexsero. Started on chest spreading, itchy. Looks like erythema multiforme minor. Prednisone and Xyzal given,
This case was reported by a consumer via interactive digital media and described the occurrence of injection site pain in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced injection site pain. On an unknown date, the outcome of the injection site pain was unknown.   It was unknown if the reporter considered the injection site pain to be related to Shingles vaccine.  Additional details were provided as follows: The patient self-reported this case. The age at vaccination was not reported. The reporter stated that aside from some local pain at the injection site, he/she had no side effects and even that was only the first shot. The follow-up would not be possible as no contact details were available.
Knot-L arm inject site. Size inc-sm fist, doubled in size in am. Swelling spread to elbow. Painful-constant burning. OT=99.2. Nausea, dizziness, diarrhea, chest pain, deep inspiration. Inject site became red, raw, clear sticky drainage.
Annular pink itchy plaque that appeared at injection site on Day 7 after 1st immunization.  Moderately itchy.  Resolved on Day 9.
Significant eye and face swelling and burning red rash on face.  Reaction began approximately 10 hours after receiving second dose of vaccine. Swelling and rash continued for 3 days.
Elevated hot wheal @ injection site 10d after administration ~2x1.5cm on L delt, no pain/itching/moisture. Responsive to diphenhydramine. Pt reports thought not present at visit, that had papular rash from feet up to knees.
Child was found unresponsive in crib on 3/21/13 am. Mom had fed at approx. 3 am and baby was fine. Found at 7 am face down in bassinet. 911 called. Pronounced dead at hospital.
Patient fainted 2 times for a few seconds after getting  Shingrix vaccine. Patient stated this was not her first time.
PT BEGAN TO FEEL DIZZY AND SHORT OF BREATH LATER THAT EVENING. THE NEXT DAY HER ARM WAS SORE AND DEVELOPED BIG RED SPOTS ON HER ARM. 2 DAYS LATER SHE CAME TO THE PHARMACY TO REPORT IT. SHE STATED SHE WAS FEELING BETTER AND FOUND OUT LATER SHE HAD INNER EAR PROBLEMS. SYMPTOMS ARE LESSENING.
Mother's history; child developed generalized rash lasting 2 months after 1st dose of Prevnar; also a fever for 4-5 days; increase in mucus with gagging; sneezing every 2 minutes X 45 minutes. Seen and treated with antibiotic. She does not know dates. After 2nd dose of Prevnar on 1/5/01, child had 4-5 spots of rash on legs, back and arm; gone by 1/9/01 and no fever. PCP history; after 1st dose Prevnar; child seen on 10/26 and given Hep-B vaccine next seen on 10/30 for sore throat and cough was  afebrile and dx'd pharyngitis. Siblings at home reported to be ill. On 11/5/00, child seen with fever of 104F, rash on inner thighs. Treated with Zithromax. On 11/6/00, seen at PCP; afebrile at 99F and non-toxic appearing. On 11/28/00, seen at PCP with rash on legs, arms, trunk and appeared to be clearing; dx'd ? viral rash. On 12/4/00, seen again at PCP and dx of rash made as Gianotti-Crosti Syndrome. On 1/5/01, seen PCP and rash cleared. 2nd dose of Prevnar given. Mother feels Prevnar was the cause of the child's symptoms despite being told by PCP this was not likely to be the cause. Mother called a number of places before reaching us and requested that the child's symptoms be reported.
Information has been received from a published article, title as stated above. This literature case was initially reported on 29-MAR-2010. This article concerned 32 patient's (8 male and 24 female) aged between one to 57 years (mean age of patients was 29 years). The patients received a RECOMBIVAX HB, manufacturer, batch number, route and site not reported, on unreported dates. This report concerns patient # 31 of 32, a 22 year old female. On an unreported date between 1982 and 2009, one to fifteen days post vaccination, the patient experienced uveitis (mean time to onset of three days). The uveitis was reported to occur after the first vaccination in 15 patients, after the second vaccination in three patients and after the third vaccination in three patients. The duration of the uveitis was not reported for nine patients. One patient had recurrent uveitis after the first and second doses of vaccine. One patient had recurrent uveitis after both the second and third doses. Patient outcome had not been reported. A 22 year old female on an unspecified date was vaccinated with a dose of RECOMBIVAX HB (lot number, route and site not reported). There was no concomitant medication. Three days after vaccination, the patient developed uveitis and on an unspecified date the patient also experienced symptoms of severe loss of vision. At the time of the report, the patient outcome was unknown. The authors stated the RECOMBIVAX HB may have a possible association with the development of uveitis in some patients. Immune complex deposition and adjuvant effects are potential pathogenic mechanisms. Uveitis was considered to be an other important medical event. Other business partner numbers include E2010-02312. Additional information has been requested. The article also discussed the experience of an additional 31 patients while on therapy with RECOMBIVAX HB (WAES #1004USA01716, WAES # 1004USA02327 to WAES # 1004USA02355 and WAES # 1004USA02357). A copy of the published article is attached as further documentation of the patient's experience.
The patient had redness and swelling on his right arm at the injection site.  The patient had symptoms of fatigue.
Dizzy,hot,shaky and felt a brief shortness of breath.  Continued to monitor.  At discharge no further problems blood pressure 124/63 heart rate 97.  Skin pink warm and dry. Respirations even and unlabored.
2-3 hours after vaccine had soreness of injection site. 8 hours after vaccine had fever 101.8, shivering,  painful muscles and bones, exploding headache. symptoms didn't resolve until 2 days later.
sore arm; red; inflamed; little pinkly; itchy arm, area 2 inches by 5 inches; headache; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm), ERYTHEMA (red), INFLAMMATION (inflamed), INJECTION SITE ERYTHEMA (little pinkly) and PRURITUS (itchy arm, area 2 inches by 5 inches) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Latex allergy. Concomitant products included PANTOPRAZOLE and MONTELUKAST for an unknown indication.    On 09-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In February 2021, the patient experienced ERYTHEMA (red), INFLAMMATION (inflamed), INJECTION SITE ERYTHEMA (little pinkly) and PRURITUS (itchy arm, area 2 inches by 5 inches). On an unknown date, the patient experienced PAIN IN EXTREMITY (sore arm) and HEADACHE (headache). At the time of the report, PAIN IN EXTREMITY (sore arm) and HEADACHE (headache) had resolved and ERYTHEMA (red), INFLAMMATION (inflamed), INJECTION SITE ERYTHEMA (little pinkly) and PRURITUS (itchy arm, area 2 inches by 5 inches) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information provided.
Father reports that at 5:30 am on 8/2/12 found child to be pale and complaining of pain in the left leg. Father reports that he removed the bandaid and the leg was significantly swollen. When the child got up he was limping and remained pale. Father states that they ate breakfast and that the child went to the bathroom and minutes later he discovered the child lying on the floor very pale even to the lips and was "twitching and shivering" but was aware of surroundings and was asking "what is wrong dad, I can't move my legs or arms". Father states that he helped the child to the toilet and became limp and collapsed twice. The father reports that the child had little muscle tone at that time. He states after a while the child improved some but remained very pale and limped and continue to complain of pain in the leg. The father took the child to the emergency room and had blood work, a UA, and a CT scan performed which were all said to be negative. He was to follow up with a Dr. later in the day. After that time the child behaved as normal.
high blood pressure; lightheadedness; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of HYPERTENSION (high blood pressure) and DIZZINESS (lightheadedness) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced HYPERTENSION (high blood pressure) and DIZZINESS (lightheadedness). At the time of the report, HYPERTENSION (high blood pressure) and DIZZINESS (lightheadedness) outcome was unknown.            No Concomitant medications were reported. No Treatment information was reported.   Reporter did not allow further contact
2nd dose not received after 28 Days; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (2nd dose not received after 28 Days) in an 82-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Apr-2021, the patient experienced PRODUCT DOSE OMISSION ISSUE (2nd dose not received after 28 Days). On 23-Apr-2021, PRODUCT DOSE OMISSION ISSUE (2nd dose not received after 28 Days) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication reported.  Treatment information not provided.     Reporter did not allow further contact
At least 2 inches cirucumference of angry bright red, hot to touch, swollen, hard area surrounding injection site.
Shooting severe pain that went up to his right groin; Fluid on his right groin; Enlarged lymph nodes on the left groin area; This spontaneous case was reported by a consumer and describes the occurrence of GROIN PAIN (Shooting severe pain that went up to his right groin), MUSCULOSKELETAL DISCOMFORT (Fluid on his right groin) and LYMPHADENOPATHY (Enlarged lymph nodes on the left groin area) in a 71-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 014M20A and 12M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 24-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 26-Oct-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 29-Oct-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced LYMPHADENOPATHY (Enlarged lymph nodes on the left groin area). In January 2022, the patient experienced GROIN PAIN (Shooting severe pain that went up to his right groin) and MUSCULOSKELETAL DISCOMFORT (Fluid on his right groin). At the time of the report, GROIN PAIN (Shooting severe pain that went up to his right groin) and MUSCULOSKELETAL DISCOMFORT (Fluid on his right groin) had not resolved and LYMPHADENOPATHY (Enlarged lymph nodes on the left groin area) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, X-ray: abnormal (abnormal) Specialist stated that they were lymph nodes and it came from the booster shot and they will go away.         No concomitant medications were provided. Treatment information includes Anti-Inflammatory for the pain.  Patient stated that the doctor recommended draining the fluid but not at the moment because it was not large enough.
Patient is reporting soreness in the arm they recieved the shingles shot, we are now 2 weeks post vaccine administration.
Patient states that about 8 hours after receiving vaccine his arm started to hurt.  Approximately 12 hours later he states that his arm went numb from his shoulder down to his elbow and he states that his fingers in that hand are freezing cold and appear to have poor circulation.  Upon visual, his hand looks swollen.  Patient states that he gets some relief with acetaminophen.  He does not have a primary care provider and does not intend to follow up with any physician.
Narrative: Pt is a 90y.o. male who died on 01/31/2021 w/ h/o PE, ckd, dm, htn, ischemic cardiomyopathy, chf- echo 9/22/16 40% EF, hyponatremia, pulmonary hypertension,remote dvt lle. Pt received Moderna Covid-19 Vaccination 1/2 on 01/31/2021. Pt died at hospital at 01/31/2021 per AOD. Unlikely that Moderna Covid-19 vaccine caused/contributed to pt death.
sore throat; wheezing; coughing up stuff; head hurts; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of OROPHARYNGEAL PAIN (sore throat), WHEEZING (wheezing), COUGH (coughing up stuff) and HEADACHE (head hurts) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included COPD, Sarcoid and Asthma.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In April 2021, the patient experienced OROPHARYNGEAL PAIN (sore throat), WHEEZING (wheezing), COUGH (coughing up stuff) and HEADACHE (head hurts). At the time of the report, OROPHARYNGEAL PAIN (sore throat), WHEEZING (wheezing), COUGH (coughing up stuff) and HEADACHE (head hurts) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medications were not provided. Treatment medications were not provided.
Information has been received from a doctor of pharmacy concerning a male (age not reported) who was vaccinated in the right arm, on an unknown date, with a dose of measles virus vaccine live + mumps virus vaccine live + rubella virus vaccine live (second generation) (lot 630621/0131J). Subsequently,the patient developed a long term transient rash on his right arm. It was unknown if the pt sought medical attention.  Additional information has been requested.
Tinitus in both ears. Appeared late April - Early May, 2021.  Reported to Dr. in 2021 and again in 2022. Went to ENT in 2021. Ringing in ears.
Excruciating headache day after vaccine, head itching and scalp swelled up to baseball size, N/V 2 days after vaccine.
A consumer report has been received. The report concerns a 5 year old, Male consumer, Weight 40.0 Pounds, who had been receiving FLUMIST quadrivalent (intranasal), 1. FLUMIST quadrivalent (intranasal) started on 25-Nov-2015. It was reported that, on 26-Nov-2015 the patient had fever 100 F. The outcome of the event of Fever 100 F is unknown. The report was considered to be non-serious.
Patient received 0.25ml of Moderna COVID-19 vaccine on 5/18/2022. Patient has no history of receiving a COVID-19 vaccine and eleigible to receive a first dose in a COVID-19 vaccine series. An additional 0.25ml of Moderna was administered immediately after. The patient received a total of 0.5ml of Moderna.
Client had aching in her arm that night, with swelling and redness (hot to touch) and it was itching by Friday. She called MD who referred her to the ER. She was given (per client) IV Benadryl in ER and prescribed oral steroid, Benadryl and an antibiotic to be taken at home. Recovery in progress. I observed client on 5/9/00, her arm was inflammed, warm to touch from the top of her shoulder to her elbow, covering approximately 1/2 the diameter of her arm. The pt tells me her arm is sore to touch.
positive COVID-19 test with symptoms; positive COVID-19 test with symptoms; This is a spontaneous report from a contactable consumer (patient), then received from a Pfizer Sponsored Program. This 38-year-old male patient received the first single dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) on 11Mar2021, in left arm, for COVID-19 immunisation. Medical history and concomitant medications were not reported. Around 22Mar2021 the patient started to show some symptoms. On 24Mar2021 he tested positive for Covid. He started quarantining on 23Mar2021 and at the time of report he was feeling fine. He hasn't had symptoms for 2-3 days during quarantine. His second vaccine dose was scheduled on 06Apr2021 but was advised to either take the vaccine or put it on hold first. Events outcome was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Employee called 11/01/2001 to report that she had developed left ear pain and achy neck accompanied by left shoulder discomfort which started Tuesday 10/30/2001. Injection given in left deltoid on Monday 10/29/2001. Also c/o left rib cage pain with a deep breath. Left arm no swelling, tenderness or redness. Physician notified, informed to take ibuprofen which she did. On 11/02/2001 she felt much better, no longer had left rib cage or shoulder pain. Still had "a little" ear and neck discomfort but improved since yesterday. Left deltoid looks fine, no redness or warmth, has full range of motion.